MOSUNETUZUMAB

UNII:	LDJ89SS0YG
Formula:
Preferred Substance Name:	MOSUNETUZUMAB
GSRS Full Record:	LDJ89SS0YG i

1905409-39-3
BTCT4465A
BTCT-4465A
IMMUNOGLOBULIN G1, HUMANIZED BISPECIFIC, ANTI-(HUMAN CD3 (ANTIGEN))(BTCT4465A .GAMMA.1-CHAIN), DISULFIDE WITH ANTI-(HUMAN CD3 (ANTIGEN)) BTCT4465A .KAPPA.4-CHAIN, ANTI-(HUMAN CD20 (ANTIGEN)) BTCT4465A .GAMMA.3-CHAIN AND ANTI-(HUMAN CD20 (ANTIGEN)) BTCT4465A .KAPPA.1-CHAIN
LUNSUMIO
MOSUNETUZUMAB [INN]
MOSUNETUZUMAB [USAN]
MOSUNETUZUMAB [WHO-DD]
MOSUNETUZUMAB AXGB [WHO-DD]
MOSUNETUZUMAB-AXGB
RG7828
RG-7828
RG-7828 (ANTI-CD20 & CD3)
RO7030816
RO-7030816

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MOSUNETUZUMAB

Synonyms and Mappings

Resources